Factors Associated with Changes in Uptake of HIV Testing Among Young Women (aged 15-24) in Tanzania from 2003 to 2012

Overview

Journal Infect Dis Poverty

Publisher Biomed Central

Date 2016 Sep 7

PMID 27595846

Citations 30

Authors

Michael J Mahande

Rune N Phimemon

Habib O Ramadhani

Affiliations

Soon will be listed here.

Abstract

Background: This study explored the factors associated with changes in HIV testing uptake among young women in Tanzania, based on an analysis of data from the 2003-2004 Tanzania HIV/AIDS Indicator Survey, and the 2007-2008 and 2011-2012 Tanzania HIV/AIDS and Malaria Indicator Surveys.

Methods: The study population consisted of young women aged 15-24 years at the time of the survey. Multivariate decomposition analysis was used to assess factors associated with changes in HIV testing uptake between the 2003-2004 and 2007-2008 surveys, and between the 2007-2008 and 2011-2012 surveys.

Results: HIV testing uptake among the study population was 7 % in 2003-2004, 31 % in 2007-2008 and 40 % in 2011-2012. The time period of the survey had a substantial effect on the uptake of HIV testing independent of other covariates. The characteristics that were significantly associated with a higher chance of HIV testing uptake across the surveys were age (20-24), education level (primary and secondary), ever being married, having at least one lifetime sexual partner, having a sexually transmitted infection or associated symptoms, and receiving antenatal care.

Conclusions: Changes in the study participants' characteristics in the 2003-2004 survey compared with the 2007-2008 survey were associated with a decrease in HIV testing uptake. Comparing the 2007-2008 survey with the 2011-2012 survey shows that the changes in the participants' characteristics contributed to 22 % of the changes in HIV testing uptake, while 78 % of the changes were attributed to coefficients.

Citing Articles

Factors Associated with HIV Testing Uptake in Cameroon: Data from the 2018 Cameroon Demographic and Health Survey.

Buh Nkum C, Nanfak A, Guenou E, Fri Kami R, Murhabazi Bashombwa A, Tchio-Nighie K HIV AIDS (Auckl). 2025; 17:9-17.

PMID: 39866749 PMC: 11766358. DOI: 10.2147/HIV.S496572.

Factors associated with HIV testing among young women in Tanzania: Insights from the 2022 Tanzanian Demographic and Health Survey using Anderson's Behavioral Model.

Abebe M, Asgedom Y, Gebrekidan A, Wondimagegne Y, Hareru H, Tebeje T Front Public Health. 2025; 12():1518314.

PMID: 39845685 PMC: 11750764. DOI: 10.3389/fpubh.2024.1518314.

The impact of the COVID-19 pandemic on HIV testing in Peru: an interrupted time series analysis from 2014 to 2022.

Yrene-Cubas R, Perez-Castilla J, Reynaga-Cottle D, Bringas M, Soriano-Moreno D, Fernandez-Guzman D BMC Infect Dis. 2025; 25(1):39.

PMID: 39773434 PMC: 11707859. DOI: 10.1186/s12879-024-10407-y.

Level and Factors Associated with Comprehensive Knowledge About HIV Among Currently Married Women in Somalia: A Nationwide Cross-Sectional Study.

Mohamud L, Aslam M HIV AIDS (Auckl). 2025; 16:485-494.

PMID: 39742138 PMC: 11687310. DOI: 10.2147/HIV.S491513.

Implementation fidelity and client satisfaction in HIV testing and counseling services: perspectives from facilities and clients in Gondar city, Northwest Ethiopia.

Terefe B, Techane M, Assimamaw N, Kebede A J Health Popul Nutr. 2024; 43(1):221.

PMID: 39702280 PMC: 11660732. DOI: 10.1186/s41043-024-00718-w.

References

Isingo R, Wringe A, Todd J, Urassa M, Mbata D, Maiseli G . Trends in the uptake of voluntary counselling and testing for HIV in rural Tanzania in the context of the scale up of antiretroviral therapy. Trop Med Int Health. 2012; 17(8):e15-25. PMC: 3443372. DOI: 10.1111/j.1365-3156.2011.02877.x. View

Miro J, Manzardo C, Mussini C, Johnson M, Monforte A, Antinori A . Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis. PLoS One. 2011; 6(10):e26009. PMC: 3197144. DOI: 10.1371/journal.pone.0026009. View

Barth R, van der Meer J, Hoepelman A, Schrooders P, van de Vijver D, Geelen S . Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis. 2008; 27(10):977-84. DOI: 10.1007/s10096-008-0534-2. View

Swenson R, Rizzo C, Brown L, Payne N, DiClemente R, Salazar L . Prevalence and correlates of HIV testing among sexually active African American adolescents in 4 US cities. Sex Transm Dis. 2009; 36(9):584-91. PMC: 3483792. DOI: 10.1097/OLQ.0b013e3181b4704c. View

Gianella S, von Wyl V, Fischer M, Niederoest B, Battegay M, Bernasconi E . Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther. 2011; 16(4):535-45. DOI: 10.3851/IMP1776. View

Tenkorang E, Maticka-Tyndale E . Individual- and school-level correlates of HIV testing among secondary school students in Kenya. Stud Fam Plann. 2013; 44(2):169-87. DOI: 10.1111/j.1728-4465.2013.00351.x. View

Cawley C, Wringe A, Slaymaker E, Todd J, Michael D, Kumugola Y . The impact of voluntary counselling and testing services on sexual behaviour change and HIV incidence: observations from a cohort study in rural Tanzania. BMC Infect Dis. 2014; 14:159. PMC: 3994406. DOI: 10.1186/1471-2334-14-159. View

Mabuto T, Latka M, Kuwane B, Churchyard G, Charalambous S, Hoffmann C . Four models of HIV counseling and testing: utilization and test results in South Africa. PLoS One. 2014; 9(7):e102267. PMC: 4094499. DOI: 10.1371/journal.pone.0102267. View

Venkatesh K, Madiba P, de Bruyn G, Lurie M, Coates T, Gray G . Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr. 2010; 56(2):151-65. PMC: 3137901. DOI: 10.1097/QAI.0b013e318202c82c. View

10.

Siegfried N, Uthman O, Rutherford G . Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010; (3):CD008272. PMC: 6599830. DOI: 10.1002/14651858.CD008272.pub2. View

11.

Peltzer K, Matseke G . Determinants of HIV testing among young people aged 18 - 24 years in South Africa. Afr Health Sci. 2014; 13(4):1012-20. PMC: 4056506. DOI: 10.4314/ahs.v13i4.22. View

12.

Abtew S, Awoke W, Asrat A . Acceptability of provider-initiated HIV testing as an intervention for prevention of mother to child transmission of HIV and associated factors among pregnant women attending at Public Health Facilities in Assosa town, Northwest Ethiopia. BMC Res Notes. 2015; 8:661. PMC: 4638027. DOI: 10.1186/s13104-015-1652-4. View

13.

Wong L, van Rooyen H, Modiba P, Richter L, Gray G, McIntyre J . Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr. 2009; 50(2):215-22. PMC: 2729272. DOI: 10.1097/QAI.0b013e3181900172. View

14.

Ziraba A, Madise N, Kimani J, Oti S, Mgomella G, Matilu M . Determinants for HIV testing and counselling in Nairobi urban informal settlements. BMC Public Health. 2011; 11:663. PMC: 3179452. DOI: 10.1186/1471-2458-11-663. View

15.

Dodd P, Garnett G, Hallett T . Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS. 2010; 24(5):729-35. PMC: 2852517. DOI: 10.1097/QAD.0b013e32833433fe. View

16.

Tenkorang E, Owusu G . Correlates of HIV testing among women in Ghana: some evidence from the Demographic and Health Surveys. AIDS Care. 2010; 22(3):296-307. DOI: 10.1080/09540120903193716. View

17.

Ivers L, Kendrick D, Doucette K . Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005; 41(2):217-24. DOI: 10.1086/431199. View

18.

Alsallaq R, Baeten J, Celum C, Hughes J, Abu-Raddad L, Barnabas R . Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013; 8(1):e54575. PMC: 3553021. DOI: 10.1371/journal.pone.0054575. View

19.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L . Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006; 367(9519):1335-42. DOI: 10.1016/S0140-6736(06)68580-2. View

20.

Baisley K, Doyle A, Changalucha J, Maganja K, Watson-Jones D, Hayes R . Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies. PLoS One. 2012; 7(7):e42108. PMC: 3405062. DOI: 10.1371/journal.pone.0042108. View